(Total Views: 1110)
Posted On: 09/18/2020 11:04:47 PM
Post# of 153775
CytoDyn will get a report I believe with the interim data analysis.
As an example, here is Vanda Pharmaceuticals' interim analysis of their Phase 3 trial for their drug Tradipitant (full study is 300 participants and this is at 60) in COVID (released 8/18/20)
https://vandapharmaceuticalsinc.gcs-web.com/node/14256/pdf
Maybe we should send this to CytoDyn as a template for how to present their interim data!
As an example, here is Vanda Pharmaceuticals' interim analysis of their Phase 3 trial for their drug Tradipitant (full study is 300 participants and this is at 60) in COVID (released 8/18/20)
https://vandapharmaceuticalsinc.gcs-web.com/node/14256/pdf
Maybe we should send this to CytoDyn as a template for how to present their interim data!
(7)
(0)
